Medicare Coverage Might Make LVADs Attractive Acquisition Targets
This article was originally published in The Gray Sheet
Executive Summary
Large cardiovascular device firms may seek to acquire or enter distribution agreements with LVAD developers, following MCAC's positive review of left-ventricular assist devices as a destination therapy